Translated Articles

《肿瘤学家》精选论文
Read translations of selected articles targeting practice issues relevant to Chinese clinicians.

The Oncologist in China

《肿瘤学家》中国项目概览
Download a 2-page pdf overview of The Oncologist’s Clinical Trial Results section information.

Video Library

视频库
Watch the latest presentations from the STO First Advisory Council: LUNG CANCER: A Grand Challenge for Public Health & Education.

Welcome to 'The Oncologist' in China

Second Annual STO-CSCO Joint Symposium

Harnessing Big Data for Precision Medicine

September 23, 2016, Xiamen International Conference and Exhibition Center, Xiamen, China


Best of The Oncologist 2016
Online translations of abstracts and selected original articles that address pressing clinical concerns. Relevant articles, in both Chinese and English, also are featured, along with a selection of Continuing Medical Education (CME) articles.

Sharing Knowledge: High Impact Review Articles from The Oncologist
A special collection of our most significant review articles from the past year. This collection covers a broad range of topics, from novel therapies to biomarkers, prognostic features, and symptom management. These articles were selected for their implication for practice.

Conference Perspectives: NSCLC Highlights: ASCO 2016
The 2016 Annual Meeting of the American Society of Clinical Oncology (ASCO), June 3-7, 2016, in Chicago, Illinois, featured key advances in non-small cell lung cancer (NSCLC) evaluation and treatment. New clinical trial evidence offered insights on the best use of approved targeted therapies, as well as a preview of next-generation therapies that will shape the future management of NSCLC.

NSCLC Collection
The Oncologist presents a collection of review articles, original research, and video lectures exploring the state of the art in the diagnosis and treatment of non-small cell lung cancer (NSCLC).

STO Chabner Colloquia: Video Collection
This annual meeting is held in collaboration with The Massachusetts General Hospital Cancer Center and designed to focus on topics that bring cancer biology to clinical application. The 2016 Chabner Colloquium is scheduled for Friday–Saturday, November 11–12, 2016, at The Liberty Hotel, Boston, MA.

Oncology Drug Development in the Era of Precision Medicine: FDA Perspective
Gideon M. Blumenthal, M.D.
Presented at the 2015 Chabner Colloquium, this video presentation features a thoughtful look at the potential for collaborative drug development, utilizing the resources of government and academic centers.

ACT China: Video Collection
Working together to bridge the gap between research and practice, The Oncologist and STO collaborate to develop important educational material and videos derived from presentations by world-acclaimed oncologists.

Submit Your Manuscript or Clinical Trial Results to The Oncologist
The Oncologist encourages submissions from all fields of cancer medicine, including medical oncology, surgical oncology, radiation oncology, pediatric oncology, cancer prevention and outreach, and population science. Highest priority is given to manuscripts with clear potential for application to the current or future practice of cancer medicine. Clinical Trial Results (CTR) is a proven open-access format for rapidly sharing results of clinical trials regardless of outcome. CTR promotes the mission of sharing these results to speed discoveries.

No front page content has been created yet.

 

The Oncologist and the Society for Translational Oncology (STO) partner with the Chinese Society of Clinical Oncology (中国抗癌协会临床肿瘤学协作专业委员会, CSCO) and the CSCO Foundation (中国临床肿瘤学会基金会) on educational initiatives that address critical health and cancer care issues in China. These efforts serve to foster communication between Chinese physicians and other leaders in oncology practice throughout the world.